Target Details
| UniProt AC | P49841 |
|---|---|
| Gene Symbol | GSK3B |
| Protein Name | Glycogen synthase kinase-3 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 2,206
- Clinical molecules 168
- Avg pChEMBL 7.19
KEGG Pathways (49)
- Alcoholic liver disease
- Alzheimer disease
- Axon guidance
- B cell receptor signaling pathway
- Basal cell carcinoma
- Breast cancer
- Cadherin signaling
- Cell cycle
- Chemokine signaling pathway
- Colorectal cancer
- Cushing syndrome
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- Gastric cancer
- Growth hormone synthesis, secretion and action
- Hedgehog signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Hippo signaling pathway
- Human cytomegalovirus infection
- Human papillomavirus infection
- IL-17 signaling pathway
- IgSF CAM signaling
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- Melanogenesis
- Neurotrophin signaling pathway
- Non-alcoholic fatty liver disease
- PI3K-Akt signaling pathway
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Prion disease
- Prolactin signaling pathway
- Prostate cancer
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Wnt signaling pathway
- Yersinia infection
- mTOR signaling pathway
Active Molecules (2,206)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
QSXQMPVZQTYTNO
|
6.1 | IC50 | 2 | — | |
ROPFCXUWNMYMSW
|
6.1 | IC50 | 10 | — | |
TZZQSURAGPGEIF
|
6.1 | IC50 | 2 | — | |
WAJYOJVNNBMVIM
|
6.1 | IC50 | 6 | Yes | |
FGSXBNALMJRFIO
|
6.1 | IC50 | 2 | — | |
LQYRKZBWHQGRGZ
|
6.1 | IC50 | 2 | — | |
CAAGBGIETNHIBK
|
6.0 | IC50 | 2 | — | |
IGFXNXIRVKBKLL
|
6.0 | IC50 | 2 | — | |
IWISRWPEVRRXIO
|
6.0 | IC50 | 2 | — | |
LBNUFTOENPMFSK
|
6.0 | Ki | 3 | — | |
YAKJZHVHEIOVIR
|
6.0 | IC50 | 2 | Yes | |
MDWYQYJBHPWFDF
|
6.0 | IC50 | 2 | — | |
MJQUKUIDCUNAAB
|
6.0 | IC50 | 4 | — | |
QNWXRLPZIFMTBK
|
6.0 | IC50 | 12 | — | |
WVMANZPBOBRWCB
|
6.0 | IC50 | 9 | — | |
JTVBXQAYBIJXRP
|
6.0 | Kd | 20 | — | |
WCVCWAQJIQBEBG
|
6.0 | IC50 | 2 | — | |
YVQOYBIBWBAHKH
|
6.0 | Kd | 12 | — | |
ANNBIHIYKLSLPB
|
6.0 | IC50 | 2 | — | |
BWKADHBOXYDZFU
|
6.0 | IC50 | 10 | — | |
KDKUVYLMPJIGKA
|
6.0 | Kd | 91 | Yes | |
IUEJEHPLFBVXJH
|
6.0 | IC50 | 2 | — | |
IYFIEJRWVMLGOG
|
6.0 | Ki | 3 | — | |
OHNNRNYUHNGDNO
|
6.0 | IC50 | 15 | — | |
TXWNHARHLAMUFF
|
6.0 | IC50 | 2 | — | |
VPOGRVWIIVMWRI
|
6.0 | IC50 | 2 | — | |
BQALMWBXRVWKAM
|
6.0 | IC50 | 2 | — | |
CBALVKLWBKZXIX
|
6.0 | IC50 | 3 | Yes | |
CYLYPHIGBMPKCK
|
6.0 | Ki | 6 | — | |
DPEXRCOBPACFOO
|
6.0 | Ki | 36 | — | |
DWHVZCLBMTZRQM
|
6.0 | IC50 | 6 | — | |
HDRKTFQABULLHE
|
6.0 | IC50 | 2 | — | |
HGILUFKJFSZULZ
|
6.0 | IC50 | 2 | — | |
HXDDWVMJYDULAZ
|
6.0 | Ki | 13 | — | |
IAEAEWGHRXXLML
|
6.0 | IC50 | 2 | — | |
IILNBGZKSQQREW
|
6.0 | Ki | 6 | — | |
IVVSBEQDCAZLFY
|
6.0 | IC50 | 333 | — | |
JPOSFPUHBHRUAX
|
6.0 | Ki | 40 | Yes | |
KHVVJKLNKLQLJZ
|
6.0 | IC50 | 288 | — | |
KKYPRNBBPBRJQX
|
6.0 | Ki | 40 | — | |
LSZUFMXSTJOZFE
|
6.0 | Ki | 9 | — | |
MAHFVAHPQSLLJF
|
6.0 | IC50 | 288 | — | |
MIJMZVTYIXYSDK
|
6.0 | Ki | 4 | — | |
MKRBAPNEJMFMHU
|
6.0 | IC50 | 2 | — | |
MNEBTNXXCJJUOW
|
6.0 | Ki | 7 | — | |
NRZYTPAJGVTKIM
|
6.0 | Ki | 38 | — | |
ODNOTLMFNVWFTJ
|
6.0 | Ki | 11 | — | |
PTVPBWWDGZSEAF
|
6.0 | Ki | 63 | — | |
SGHQPTXSHFASJK
|
6.0 | Ki | 2 | — | |
SYFFUKLBOFFLLY
|
6.0 | IC50 | 2 | — |